SCHEMBL14113111

SCHEMBL14113111

Cc1cc(=O)oc2c(CC=O)c(NC(=O)OCC(Cl)(Cl)Cl)ccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 6/20 0.48
▸ KDM4E B2RXH2 6/20 0.43
▸ HPGD P15428 6/20 0.43
▸ ALDH1A1 P00352 5/20 0.43
▸ HSD17B10 Q99714 5/20 0.43
▸ NPC1 O15118 2/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ MAOB P27338 7/20 0.41
▸ ERN1 O75460 1/20 0.40
▸ GLA P06280 3/20 0.39
▸ GAA P10253 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ MAPT P10636 2/20 0.39
▸ CASP1 P29466 2/20 0.39
▸ CASP7 P55210 2/20 0.39
▸ CASP3 P42574 1/20 0.39
▸ SENP8 Q96LD8 1/20 0.39
▸ SENP7 Q9BQF6 1/20 0.39
▸ SENP6 Q9GZR1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4928161 0.90 MAOA (0.47) MAOAKDM4EHPGDALDH1A1HSD17B10
SCHEMBL4927779 0.67 MAOA (0.42) MAOAKDM4EHPGDALDH1A1HSD17B10
SCHEMBL20460460 0.66 SMN1; SMN2 (0.52) ALDH1A1NPC1RAB9ASMN1; SMN2GAA
SCHEMBL4929441 0.65 ALPL (0.49) KDM4EHPGDALDH1A1HSD17B10ERN1
SCHEMBL14088013 0.65 CA12 (0.60) KDM4EHPGDALDH1A1HSD17B10NPC1
SCHEMBL20460463 0.64 SMN1; SMN2 (0.50) HPGDALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL4919565 0.63 MAOA (0.39) MAOAKDM4EHPGDALDH1A1HSD17B10
SCHEMBL6197998 0.63 LMNA (0.49) HPGDALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL18615673 0.62 ALDH1A1 (0.54) KDM4EHPGDALDH1A1SMN1; SMN2GAA
SCHEMBL3878331 0.61 CA9 (0.65) MAOAKDM4EHPGDALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) MAOA, MAOB, COMT MAOA 1/4885KDM4E 1183/4885HPGD 296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback